Soluble metalloendopeptidases and neuroendocrine signaling.
暂无分享,去创建一个
A Ian Smith | R. Lew | A. Smith | Corie N Shrimpton | Rebecca A Lew | C. N. Shrimpton | A. I. Smith | C. Shrimpton
[1] A. Kato,et al. Cloning, amino acid sequence and tissue distribution of porcine thimet oligopeptidase. A comparison with soluble angiotensin-binding protein. , 1994, European journal of biochemistry.
[2] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.
[3] F. Cozzolino,et al. A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence. , 1990, The EMBO journal.
[4] J. Roberts,et al. Substrate specificity differences between recombinant rat testes endopeptidase EC 3.4.24.15 and the native brain enzyme. , 1995, Biochemical and biophysical research communications.
[5] M. Orłowski,et al. A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides. , 1983, European journal of biochemistry.
[6] A. Beaudet,et al. Light and Electron Microscopic Localization of the Neutral Metalloendopeptidase EC 3.4.24.16 in the Mesencephalon of the Rat , 1992, The European journal of neuroscience.
[7] E. Daniel,et al. Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum , 1994, British journal of pharmacology.
[8] A. Barrett,et al. Chicken liver Pz-peptidase, a thiol-dependent metallo-endopeptidase. , 1990, The Biochemical journal.
[9] A. Pierotti,et al. Expression of the thimet oligopeptidase gene is regulated by positively and negatively acting elements. , 2000, DNA and cell biology.
[10] F. Checler,et al. Development of the First Potent and Selective Inhibitor of the Zinc Endopeptidase Neurolysin Using a Systematic Approach Based on Combinatorial Chemistry of Phosphinic Peptides* , 1996, The Journal of Biological Chemistry.
[11] F. Checler. Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's Disease , 1995 .
[12] C. Ferrario,et al. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. , 2000, Hypertension.
[13] P. Xu,et al. Human endopeptidase (THOP1) is localized on chromosome 19 within the linkage region for the late-onset alzheimer disease AD2 locus. , 1996, Genomics.
[14] T. Saido,et al. Metabolic Regulation of Brain Aβ by Neprilysin , 2001, Science.
[15] M. Orłowski,et al. Immunohistochemical localization of endopeptidase 24.15 in rat trachea, lung tissue, and alveolar macrophages. , 1990, American journal of respiratory cell and molecular biology.
[16] J. Rossier,et al. Brain Endo‐Oligopeptidase A, a Putative Enkephalin Converting Enzyme , 1987, Journal of neurochemistry.
[17] I. Clarke,et al. Peptidases that Degrade Gonadotropin‐Releasing Hormone: Influence on LH Secretion in the Ewe , 1997, Journal of neuroendocrinology.
[18] S. Hirose,et al. Molecular cloning of porcine soluble angiotensin-binding protein. , 1992, The Journal of biological chemistry.
[19] M. Orłowski,et al. Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptides, including enkephalin-containing peptides. , 1989, The Biochemical journal.
[20] M. E. Lewis,et al. Endogenous opioids: biology and function. , 1984, Annual review of neuroscience.
[21] J. Roberts,et al. Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts. , 1994, The Journal of biological chemistry.
[22] R. Barbour,et al. Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.
[23] J P Vincent,et al. Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes. , 1986, The Journal of biological chemistry.
[24] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[25] F. Checler,et al. Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides. , 1993, European journal of biochemistry.
[26] M. Orłowski,et al. Synaptosomal Membrane‐Bound Form of Endopeptidase‐24.15 Generates Leu‐Enkephalin from Dynorphin 1‐8, α‐ and β‐Neoendorphin, and Met‐Enkephalin from Met‐Enkephalin‐Arg6‐Gly7‐Leu , 1987 .
[27] L. Hersh,et al. Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.
[28] B. Roques,et al. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation. , 1997, European journal of pharmacology.
[29] A. Goldberg,et al. Major Histocompatibility Complex Class I-presented Antigenic Peptides Are Degraded in Cytosolic Extracts Primarily by Thimet Oligopeptidase* , 2001, Journal of Biological Chemistry.
[30] T. Davis,et al. Peptidases in the CNS: formation of biologically active, receptor-specific peptide fragments. , 1993, Critical reviews in neurobiology.
[31] J. Bourguignon,et al. Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. , 1999, Endocrinology.
[32] D. Selkoe,et al. Neurons Regulate Extracellular Levels of Amyloid β-Protein via Proteolysis by Insulin-Degrading Enzyme , 2000, The Journal of Neuroscience.
[33] S. Jacchieri,et al. Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase. , 1997, The Biochemical journal.
[34] D. Tambourgi,et al. Secretion of a neuropeptide-metabolizing enzyme similar to endopeptidase 22.19 by glioma C6 cells. , 1993, Biochemical and biophysical research communications.
[35] M. Orłowski,et al. A soluble metalloendopeptidase from rat brain , 1983 .
[36] R. Bodnar,et al. Antinociceptive properties of inhibitors of endopeptidase 24.15. , 1991, The International journal of neuroscience.
[37] M. Norman,et al. Metalloendopeptidases EC 3.4.24.15 and EC 3.4.24.16 And Bradykinin B2 Receptors Do Not Play Important Roles In Renal Wrap Hypertension In Rabbits , 2001, Clinical and experimental pharmacology & physiology.
[38] D. Steiner,et al. Post-translational proteolysis in polypeptide hormone biosynthesis. , 1982, Annual review of physiology.
[39] M. Orłowski,et al. Immunocytochemical localization of endopeptidase 24.15 in rat brain , 1992, Brain Research.
[40] D. Grandy,et al. Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.
[41] B. Roques,et al. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin‐induced analgesia and neuronal inactivation , 1997, British journal of pharmacology.
[42] C. Prange,et al. Human endopeptidase 24.15 (THOP1) is localized on chromosome 19p13.3 and is excluded from the linkage region for late-onset Alzheimer disease. , 1998, Genomics.
[43] J. Ayala,et al. Endopeptidase-24.15 in rat hypothalamic/pituitary/gonadal axis , 1991, Molecular and Cellular Endocrinology.
[44] B. Roques,et al. Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice , 1997, FEBS letters.
[45] N. Rawlings,et al. Evolutionary families of peptidases. , 1993, The Biochemical journal.
[46] J. Roberts,et al. The role of EC 3.4.24.15 in the post-secretory regulation of peptide signals. , 1994, Biochimie.
[47] C. Pineau,et al. Distribution of thimet oligopeptidase (E.C. 3.4.24.15) in human and rat testes. , 1999, Journal of cell science.
[48] C. Nemeroff,et al. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. , 1989, The Journal of neuropsychiatry and clinical neurosciences.
[49] A. Beaudet,et al. Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain , 2001, The Journal of comparative neurology.
[50] C. Eckman,et al. Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme* , 2001, The Journal of Biological Chemistry.
[51] J. Vane,et al. Conversion of Angiotensin I to Angiotensin II , 1967, Nature.
[52] Characterization of an endooligopeptidase A‐like protein in PC12 cells: Activity modulation by cAMP but not by basic fibroblast growth factor , 1995, Journal of cellular biochemistry.
[53] J. Roberts,et al. Secretion of metalloendopeptidase 24.15 (EC 3.4.24.15). , 1999, DNA and cell biology.
[54] L. Juliano,et al. Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol. , 1999, Biochemical and biophysical research communications.
[55] E. Davie,et al. Rabbit liver microsomal endopeptidase with substrate specificity for processing proproteins is structurally related to rat testes metalloendopeptidase 24.15. , 1993, The Journal of biological chemistry.
[56] J. Roberts,et al. Molecular cloning and primary structure of rat testes metalloendopeptidase EC 3.4.24.15. , 1990, Biochemistry.
[57] Takehiko Hosoiri,et al. Targeting of Endopeptidase 24.16 to Different Subcellular Compartments by Alternative Promoter Usage* , 1997, The Journal of Biological Chemistry.
[58] H. Gainer,et al. The enzymology and intracellular organization of peptide precursor processing: the secretory vesicle hypothesis. , 1985, Neuroendocrinology.
[59] N. Jaiswal,et al. Angiotensin-(1-7): a new hormone of the angiotensin system. , 1991, Hypertension.
[60] L. Juliano,et al. Characterization of thiol‐, aspartyl‐, and thiol‐metallo‐peptidase activities in Madin‐Darby canine kidney cells , 2000, Journal of Cellular Biochemistry.
[61] G. Fink,et al. Endopeptidase EC 3.4.24.15 Presence in the Rat Median Eminence and Hypophysial Portal Blood and its Modulation of the Luteinizing Hormone Surge , 1997, Journal of neuroendocrinology.
[62] J. Fallon,et al. Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain , 2004, Experimental Brain Research.
[63] J. Bourguignon,et al. Gonadotropin releasing hormone inhibitory autofeedback by subproducts antagonist at N-methyl-D-aspartate receptors: a model of autocrine regulation of peptide secretion. , 1994, Endocrinology.
[64] K. Suzuki,et al. Thimet oligopeptidase cleaves the full-length Alzheimer amyloid precursor protein at a beta-secretase cleavage site in COS cells. , 1999, Journal of biochemistry.
[65] A. Igarashi,et al. Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity* , 2001, The Journal of Biological Chemistry.
[66] B. Clineschmidt,et al. Neurotensin: antinocisponsive action in rodents. , 1979, European journal of pharmacology.
[67] C. L. Silva,et al. Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation. , 1999, Biochemical and biophysical research communications.
[68] A. Coquerel,et al. Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n , 1988, Neurochemistry International.
[69] J. W. Tullai,et al. The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane , 1999, Brain Research.
[70] J. Costentin,et al. Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus , 1992, Neuroscience Letters.
[71] A. Camargo,et al. Preparation, assay, and partial characterization of a neutral endopeptidase from rabbit brain. , 1973, Biochemistry.
[72] A. Beaudet,et al. Distinct Properties of Neuronal and Astrocytic Endopeptidase 3.4.24.16: A Study on Differentiation, Subcellular Distribution, and Secretion Processes , 1996, The Journal of Neuroscience.
[73] G. Abbenante,et al. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15. , 2000, The Biochemical journal.
[74] F Wold,et al. In vivo chemical modification of proteins (post-translational modification). , 1981, Annual review of biochemistry.
[75] A. Barrett,et al. A distinct thimet peptidase from rat liver mitochondria , 1990, FEBS letters.
[76] A. K. Carmona,et al. Thimet oligopeptidase EC 3.4.24.15 is a major liver kininase. , 2000, Life sciences.
[77] R. Bodnar,et al. Increases in opioid-mediated swim antinociception following endopeptidase 24.15 inhibition , 1991, Physiology & Behavior.
[78] N. Hooper,et al. Angiotensin converting enzyme: implications from molecular biology for its physiological functions. , 1991, The International journal of biochemistry.
[79] A. Camargo,et al. Presence of endo-oligopeptidase (EC 3.4.22.19), a putative neuropeptide-metabolizing endopeptidase in cells of the immune system , 1992, Journal of Neuroimmunology.
[80] C. Abraham,et al. Identification of a metalloprotease from Alzheimer's disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments. , 1994, Biochemistry.
[81] F. Checler,et al. Specific inhibition of endopeptidase 24.16 by dipeptides. , 1991, European journal of biochemistry.
[82] M. D. Gomes,et al. Species specificity of thimet oligopeptidase (EC 3.4.24.15). , 1996, Biological chemistry Hoppe-Seyler.
[83] L. Juliano,et al. Structural requirements of bioactive peptides for interaction with endopeptidase 22.19 , 1994, Neuropeptides.
[84] F. Checler,et al. Stably Transfected Human Cells Overexpressing Rat Brain Endopeptidase 3.4.24.16: Biochemical Characterization of the Activity and Expression of Soluble and Membrane‐Associated Counterparts , 1997, Journal of neurochemistry.
[85] F. Checler,et al. Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum. , 1988, European journal of biochemistry.
[86] M. Orłowski,et al. Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone. , 1989, The Journal of pharmacology and experimental therapeutics.
[87] S. Snyder,et al. Enkephalin convertase: purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[88] J. Palacios,et al. Neurotensin receptors are located on dopamine-containing neurones in rat midbrain , 1981, Nature.
[89] J. Roberts,et al. Thiol Activation of Endopeptidase EC 3.4.24.15 , 1997, The Journal of Biological Chemistry.
[90] M. Orłowski,et al. Substrate-related potent inhibitors of brain metalloendopeptidase. , 1988, Biochemistry.
[91] J. Mcdermott,et al. Peptidases involved in the catabolism of neurotensin: Inhibitor studies using superfused rat hypothalamic slices , 1986, Peptides.
[92] E. Mascha,et al. Effects of a Metalloendopeptidase‐24.15 Inhibitor on Renal Hemodynamics and Function in Rats , 1994, Hypertension.
[93] M. Goedert,et al. Examination of the role of endopeptidase 3.4.24.15 in Aβ secretion by human transfected cells , 1997, British journal of pharmacology.
[94] B. Roques,et al. Nociceptin/Orphanin FQ Metabolism: Role of Aminopeptidase and Endopeptidase 24.15 , 1997, Journal of neurochemistry.
[95] R. Skidgel. Bradykinin‐Degrading Enzymes: Structure, Function, Distribution, and Potential Roles in Cardiovascular Pharmacology , 1992, Journal of cardiovascular pharmacology.
[96] T. Davis,et al. Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices. , 1994, The Journal of pharmacology and experimental therapeutics.
[97] J. Mcdermott,et al. Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer beta-amyloid protein from its precursor. , 1992, Biochemical and biophysical research communications.
[98] Y. Ibata,et al. The location of LH-RH neurons in the rat hypothalamus and their pathways to the median eminence , 1979, Cell and Tissue Research.
[99] D. Walsh,et al. Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme. , 1993, The Biochemical journal.
[100] F. Checler,et al. Molecular Cloning and Expression of Rat Brain Endopeptidase 3.4.24.16 (*) , 1995, The Journal of Biological Chemistry.
[101] P. Emson,et al. Involvement of Endo‐Oligopeptidases A and B in the Degradation of Neurotensin by Rabbit Brain , 1984, Journal of neurochemistry.
[102] J. S. Jacobsen,et al. Evaluation of Cathepsins D and G and EC 3.4.24.15 as Candidate β‐Secretase Proteases Using Peptide and Amyloid Precursor Protein Substrates , 1996, Journal of neurochemistry.
[103] Shin‐Rong Hwang,et al. Proteases and the emerging role of protease inhibitors in prohormone processing , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] James L. Roberts,et al. Differential subcellular distribution of neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) in the rat brain , 1999, Brain Research.
[105] M. Orłowski,et al. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1 (R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme , 1993, Peptides.
[106] D. Rodgers,et al. Structure of neurolysin reveals a deep channel that limits substrate access , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[107] C. Nemeroff,et al. Reduced CSF neurotensin concentration in drug-free schizophrenic patients , 1988, Schizophrenia Research.
[108] R. Evans,et al. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits , 1996, British journal of pharmacology.
[109] A. Beaudet,et al. Distribution of neurotensin binding sites in rat brain: A light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin , 1987, Neuroscience.
[110] J. Krause,et al. Luteinizing hormone-releasing hormone peptidase activities in discrete hypothalamic regions and anterior pituitary of the rat: apparent regulation during the prepubertal period and first estrous cycle at puberty. , 1982, Endocrinology.
[111] J. Martignetti,et al. The Neuropeptide Processing Enzyme EC 3.4.24.15 Is Modulated by Protein Kinase A Phosphorylation* , 2000, The Journal of Biological Chemistry.
[112] A. Turner,et al. Isoforms of endothelin-converting enzyme: why and where? , 1998, Trends in pharmacological sciences.
[113] S. Hunt,et al. Localization of Endo‐Oligopeptidase (EC 3.4.22.19) in the Rat Nervous Tissue , 1990, Journal of neurochemistry.
[114] B. A. Lessley,et al. Identification and distribution of Pz-peptidases A and B in human semen. , 1985, Journal of andrology.
[115] R. Evans,et al. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor , 1995, British journal of pharmacology.
[116] B. Horsthemke,et al. Characterization of a nonchymotrypsin-like endopeptidase from anterior pituitary that hydrolyzes luteining hormone-releasing hormone at the tyrosyl-glycine and histidyl-tryptophan bonds. , 1980, Biochemistry.
[117] A. Beaudet,et al. Confocal microscopy reveals thimet oligopeptidase (EC 3.4.24.15) and neurolysin (EC 3.4.24.16) in the classical secretory pathway. , 1999, DNA and cell biology.
[118] D. Ganten,et al. Converting enzyme determines plasma clearance of angiotensin-(1-7). , 1998, Hypertension.
[119] F. Checler,et al. Colocalization of neurotensin receptors and of the neurotensin- degrading enzyme endopeptidase 24-16 in primary cultures of neurons , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[120] N. Rawlings,et al. Thimet oligopeptidase and oligopeptidase M or neurolysin. , 1995, Methods in enzymology.
[121] E. Genden,et al. Inhibition of Endopeptidase‐24.15 Decreases Blood Pressure in Normotensive Rats , 1991, Hypertension.
[122] J. Bourguignon,et al. Early Prepubertal Ontogeny of Pulsatile Gonadotropin-Releasing Hormone (GnRH) Secretion: I. Inhibitory Autofeedback Control through Prolyl Endopeptidase Degradation of GnRH1. , 1999, Endocrinology.
[123] M. Glucksman,et al. Zinc Coordination and Substrate Catalysis within the Neuropeptide Processing Enzyme Endopeptidase EC 3.4.24.15 , 1999, The Journal of Biological Chemistry.
[124] R. Mains,et al. Peptide alpha-amidation. , 1988, Annual review of physiology.
[125] M. Orłowski,et al. Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides. , 1985, Endocrinology.
[126] C. Nemeroff,et al. SUBNORMAL CSF LEVELS OF NEUROTENSIN IN A SUBGROUP OF SCHIZOPHRENICS AND NORMALIZATION AFTER NEUROLEPTIC TREATMENT , 1982, The American journal of psychiatry.
[127] A. Turner,et al. Molecular pharmacology of endothelin converting enzymes. , 1996, Biochemical pharmacology.
[128] M. Orłowski,et al. Inhibition of endopeptidase 24.15 greatly increases the release of luteinizing hormone and follicle stimulating hormone in response to luteinizing hormone/releasing hormone. , 1990, The Journal of pharmacology and experimental therapeutics.
[129] F. Checler,et al. Neurotensin metabolism in various tissues of central and peripheral origins: ubiquitous involvement of a novel neurotensin degrading metalloendopeptidase. , 1988, Biochimie.
[130] L. Juliano,et al. Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin. , 2001, Biochemistry.
[131] N. Rawlings,et al. [32] Thimet oligopeptidase and oligopeptidase M or neurolysin , 1995 .
[132] R. Mentlein,et al. Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. , 1992, European journal of biochemistry.
[133] A. Barrett,et al. Human thimet oligopeptidase. , 1993, The Biochemical journal.
[134] B. Roques. Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives. , 1998, Pathologie-biologie.
[135] B. Horsthemke,et al. Substrate specificity of an adenohypophyseal endopeptidase capable of hydrolyzing luteinizing hormone-releasing hormone: preferential cleavage of peptide bones involving the carboxyl terminus of hydrophobic and basic amino acids. , 1982, Biochemistry.
[136] M. Orłowski,et al. Endopeptidase‐24.15 Is the Primary Enzyme that Degrades Luteinizing Hormone Releasing Hormone Both In Vitro and In Vivo , 1988, Journal of neurochemistry.
[137] O. Carretero,et al. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. , 1987, Kidney international.
[138] L. Hersh,et al. Endopeptidase 24.16B , 1995, The Journal of Biological Chemistry.
[139] K. Nakagawa,et al. Tissue Distribution and Subcellular Localization of Rabbit Liver Metalloendopeptidase , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[140] Conversion and inactivation of opioid peptides by rabbit brain endo-oligopeptidase A. , 1985, Biochemical and biophysical research communications.
[141] R. Mentlein,et al. Endopeptidases 24.16 and 24.15 Are Responsible for the Degradation of Somatostatin, Neurotensin, and Other Neuropeptides by Cultivated Rat Cortical Astrocytes , 1994, Journal of neurochemistry.
[142] Marc Parmentier,et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.
[143] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[144] J. Ayala,et al. An Inhibitor of Endopeptidase‐24.15 Blocks the Degradation of Intraventricularly Administered Dynorphins , 1990, Journal of neurochemistry.
[145] J. Sloane,et al. Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer’s Amyloid-β Peptide Degradation* , 1999, The Journal of Biological Chemistry.
[146] F. Checler,et al. Inactivation of Neurotensin by Rat Brain Synaptic Membranes Partly Occurs Through Cleavage at the Arg8‐Arg9 Peptide Bond by a Metalloendopeptidase , 1985, Journal of neurochemistry.
[147] C. Nemeroff,et al. The Neurobiology of Neurotensin , 1992 .
[148] F. Checler,et al. Development of Highly Potent and Selective Phosphinic Peptide Inhibitors of Zinc Endopeptidase 24-15 Using Combinatorial Chemistry (*) , 1995, The Journal of Biological Chemistry.
[149] P. Perlmutter,et al. Bradykinin analogues with β‐amino acid substitutions reveal subtle differences in substrate specificity between the endopeptidases EC 3.4.24.15 and EC 3.4.24.16 , 2000, Journal of peptide science : an official publication of the European Peptide Society.
[150] T. Hökfelt,et al. Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons , 1984, The Journal of comparative neurology.
[151] F. Checler,et al. Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies. , 1989, The Biochemical journal.
[152] J. Roberts,et al. Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. , 1998, Biochemical and biophysical research communications.
[153] A. Barrett,et al. Characterization of a Mitochondrial Metallopeptidase Reveals Neurolysin as a Homologue of Thimet Oligopeptidase (*) , 1995, The Journal of Biological Chemistry.
[154] A. Turner,et al. Purification and properties of a neurotensin-degrading endopeptidase from pig brain. , 1991, The Biochemical journal.
[155] R. Evans,et al. A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotension. , 2000, Hypertension.
[156] N. Seidah,et al. Proprotein Convertases , 2011, Methods in Molecular Biology.
[157] C. Boustead,et al. Cell-surface peptidases in health and disease , 1997 .
[158] N. Rawlings,et al. Thimet oligopeptidase: similarity to 'soluble angiotensin II-binding protein' and some corrections to the published amino acid sequence of the rat testis enzyme. , 1993, The Biochemical journal.
[159] D. Tambourgi,et al. Molecular and immunochemical evidences demonstrate that endooligopeptidase A is the predominant cytosolic oligopeptidase of rabbit brain. , 2000, Biochemical and biophysical research communications.
[160] N. Seidah,et al. Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.